Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Grant or award Director acquired 8,000 shares (grant or award)
  2. 4 Grant or award Director acquired 8,000 shares (grant or award)
  3. 4 Grant or award Director acquired 8,000 shares (grant or award)
  4. 4 Grant or award Director acquired 8,000 shares (grant or award)
  5. 4 Grant or award Director acquired 8,000 shares (grant or award)
  6. 4 Grant or award Director acquired 8,000 shares (grant or award)
  7. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  9. 4 Open-market sale Director sold 9,000 shares at $19.06 ($171,540)
  10. 4 Open-market sale Director sold 7,500 shares at $19.13 ($143,475)
  11. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  13. 4 Open-market sale Director sold 12,000 shares at $19.21 ($230,520)
  14. 4 Open-market sale President & CEO sold 87,500 shares at $17.83 ($1,560,125)
  15. 4 Open-market sale SVP & Chief Operating Officer sold 3,317 shares at $17.56 ($58,247)
  16. 4 Open-market sale SVP & Chief Accounting Officer sold 3,971 shares at $17.56 ($69,731)
  17. 4 Open-market sale President & CEO sold 11,817 shares at $17.56 ($207,507)
  18. 4 Open-market sale SVP & Chief Financial Officer sold 3,305 shares at $17.56 ($58,036)
  19. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 3,305 shares at $17.56 ($58,036)
  20. 4 Open-market sale SVP & Chief Medical Officer sold 1,685 shares at $17.56 ($29,589)

Page 24 of 49 · 970 filings